Italian Pharmaceutical Workshop

What Italian Pharmaceutical Workshop does

Officina Farmaceutica Italiana (OFI) is an Italian contract development and manufacturing organization (CDMO) headquartered in Bergamo, founded in 1946 by Attilio Donati. The company manufactures three product categories on a B2B full-service basis — food supplements, medical devices (Class I, IIA, IIB, and III), and dermo-cosmetics — operating from three production sites totaling 12,000 square meters, including Class 100,000 air filtration, two Class 1000 cleanrooms for sterile processing, reverse-osmosis water systems, and 6,500 square meters of robotic, temperature/humidity-controlled warehousing. Its technical capabilities span a wide range of formats (stickpacks, single- and multi-dose bottles, tubes, jars, vials, tablets, capsules, biphasic and triphasic vials, gummies, softgels, and the proprietary ICEPOP frozen stickpack), supported by in-house formulation R&D, regulatory affairs, and quality assurance. Notable proprietary technologies include the patented SKIN UP hybrid skincare-makeup formulation (registered September 2020) and a Class IIA CE-marked medical device for gastroesophageal reflux using alginate/Opuntia ficus indica chemistry. Certifications include ISO 9001, 14001, 22716, 13485, 45001, FDA approval, Halal, ICEA Eco Bio Cosmetics, and EU MDR (with several devices first-in-Italy approved).

OFI's commercial model is built on full-service contract manufacturing: it develops formulations, handles regulatory dossiers, produces, packages, stores, and ships on behalf of B2B customers, while also out-licensing CE-marked medical devices for distribution under customer brands and operating a small factory shop at Via Andrea Verga 18 in Bergamo for OFI-branded skincare, sun care, and supplements. Its distribution channels are direct B2B sales (supplemented by a website product configurator and a multilingual Italian/English web presence) and a licensing channel for medical devices. Since December 2020 the company has been controlled by Investindustrial, which combined OFI with sister company Farmaceutici Procemsa to form the OURVITA group; the Donati family retained a minority stake, Alberto Donati serves as President, Alessandro Sertorio as group CEO, Filippo Sertorio as group CFO, and Luca Testa as CEO of OFI. The company is currently focused on international expansion into the United States, China, and the Far East, supported by trade show activity at VITAFOODS Geneva, CPHI Frankfurt, and COSMOPROF Asia Singapore.

Name

Italian Pharmaceutical Workshop

Legal name

OFI SPA – OFFICINA FARMACEUTICA ITALIANA

Website

https://ofi.it

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

51–100 employees

Short description

Officina Farmaceutica Italiana (OFI) is a Bergamo-based Italian CDMO founded in 1946, contract-manufacturing food supplements, medical devices (Class I-IIIA), and dermo-cosmetics for B2B brands from three GMP production sites, with full-service capabilities from formulation to logistics.

Ownership category

akta.pro rank

Product category

Contract Pharmaceutical and Nutraceutical Manufacturing (CDMO)

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ)

Keywords

• Contract pharmaceutical manufacturing
• Nutraceutical contract development
• Medical device manufacturing
• Dermo-cosmetic production
• CDMO services

Headquarters

HQ city

Bergamo

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Full-service contract development and manufacturing for food supplements, medical devices, and dermo-cosmetics. Revenue generated through manufacturing fees, formulation development fees, regulatory services, and production contracts with B2B customers.
2. Out-Licensing of Medical Devices: OFI supplies CE-marked medical devices ready for distribution under customer brands, generating licensing revenue from pre-approved product portfolios.
3. Factory Shop Retail Sales: Direct retail sales of OFI-labelled skin care products, sun products, and dietary supplements through company-owned factory shop located at Via Andrea Verga 18, Bergamo.
4. Professional Services: Additional services including formulation research and development, marketing consultancy, regulatory affairs support, quality assurance, warehouse and logistics, and after-sales assistance.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Officina Farmaceutica Italiana (OFI) is a full-service Contract Development and Manufacturing Organization (CDMO) that develops, formulates and manufactures food supplements, medical devices (Class I, IIA, IIB, III), and dermo-cosmetics on behalf of B2B brand customers. The company operates three GMP-compliant production sites totaling 12,000 square meters, providing end-to-end services from R&D and regulatory affairs through production, quality assurance, warehouse/logistics, and after-sales support. The company also distributes its own proprietary brands (Bottega di LungaVita, Euronatural, Kosmida, Dr Albert, SPA LINE) and offers out-licensing of CE-marked medical devices.

Product overview

Officina Farmaceutica Italiana (OFI) is a Contract Development and Manufacturing Organization (CDMO) established in 1946, operating as a Full Service provider for Food Supplements, Medical Devices (Class I, IIA, IIB, III), and Dermo-Cosmetics. The company offers comprehensive contract manufacturing from idea to finished product through seven integrated service pillars: formulation research and development, marketing consultancy, regulatory affairs, production, quality assurance, warehouse and logistics, and after-sales assistance. OFI maintains five proprietary brands for distribution (Bottega di LungaVita, Euronatural, Kosmida, Dr Albert, SPA LINE), while also providing out-licensing of CE-marked medical devices. The company operates three production sites totaling 12,000 square meters with advanced capabilities including stickpacks, gummies, ICEPOP frozen supplements, hybrid cosmetics (SKIN UP), probiotics, and fermented skincare. Innovation is central to OFI's offering, demonstrated by patented hybrid cosmetic products, innovative supplement formats, and continuous development of new formulations and delivery systems.

Differentiator

Problem solved

Functional benefit

Brands

• Bottega di LungaVita: Natural products combining age-old traditions with scientific innovation. Sold in Italy in herbal and natural shops, pharmacies and para-pharmacies, and distributed abroad.
• Euronatural
• Kosmida
• Dr Albert
• SPA LINE

Products and services

• Food Supplements (Integratori) - Contract Manufacturing Contract development and manufacturing of dietary food supplements across multiple therapeutic areas (pediatric, immune, gastroenterology, gynecology, neurology, respiratory, vitamins, sport, dermatology, beauty, cardiology, weight control) and delivery formats (liquids, stickpacks, tablets, capsules, gummies). For B2B brand customers seeking outsourced nutraceutical manufacturing.
• Medical Devices (Dispositivi Medici) - Contract Manufacturing & Out-Licensing Contract manufacturing of medical devices Class I, IIA, IIB, and III in therapeutic areas including nasal mucous membranes, oropharyngeal cavity, vaginal mucous membranes, pediculosis, UV protection, dermatology, gastroesophageal reflux, and proctology. Includes out-licensing of CE-marked devices for distribution under customer brands. For B2B medical device companies and distributors.
• Cosmetics (Cosmetici) - Contract Manufacturing Contract manufacturing of dermo-cosmetic products for face, body, sun protection, hair care, and personal care. Includes innovative hybrid forms (skincare-makeup), probiotic cosmetics, fermented skincare, and sustainable packaging options. For B2B cosmetic brands requiring certified manufacturing (ISO 22716 GMP) with high-quality raw materials.
• Full Service - Contract Development and Manufacturing End-to-end CDMO service from idea to finished product covering seven integrated pillars: formulation R&D, marketing consultancy, regulatory affairs, production, quality assurance, warehouse and logistics, and after-sales support. For B2B brand customers seeking an outsourced partner across the entire nutraceutical, medical device, or cosmetic product lifecycle.
• Formulation Research and Development Standalone R&D service combining creativity and specialist pharmaceutical technology skills, including study of new raw materials, creation of new formulations, innovative textures and aromas, new packaging applications, and primary/secondary packaging compatibility studies. For B2B customers seeking innovation support.
• Regulatory Affairs Service Worldwide regulatory support for placing products on the market, including product registration in Italy and abroad, preparation of pre-registration documents, legislative compliance assessment and maintenance, and management of product certifications. For B2B customers needing market access support across jurisdictions.
• Quality Assurance Service Chemical, physical, and microbiological controls following UNI EN ISO 2859 and European Pharmacopoeia standards, including instrument calibration, reference sample management, environmental monitoring, batch stability control, and total product traceability. For B2B customers requiring validated quality systems.
• Warehouse and Logistics Service 6,500 square meters of computerized warehouses across three facilities with humidity and temperature control, customer materials stocking, fully robotic warehouses, and automated pallet change systems compliant with pharmaceutical standards. For B2B customers requiring integrated storage and distribution.
• Bottega di LungaVita Brand (dietary supplements and natural products) Proprietary OFI brand offering natural and organic products combining age-old traditions with scientific innovation for herbal shops, pharmacies, and para-pharmacies in Italy and abroad. For retail and distribution partners.
• Euronatural Brand (dietary supplements) Proprietary OFI brand of dietary supplements including vitamins, probiotics, iron and folic acid, omega 3, primarily in liquid forms and practical mono-dose liquid sachets. For retail distribution partners.
• Dr Albert Brand (footcare products) Proprietary OFI brand of footcare products providing treatments for foot fitness, tonicity, and protection against pathologies like mycosis, callous surfaces, and blisters. For retail and pharmacy distribution.
• SPA LINE Brand (thalasso cosmetics) Proprietary OFI brand of thalasso cosmetics featuring mineral and natural wellness formulations from San Pellegrino thermal tradition, serving beauty centers and spas. For spa and beauty center distribution.

Quantifiable outcome

• Total product traceability from raw materials to finished product
• +2 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Farmaceutici ProcemsacoreStrategic or Co-development Partner · 16 December 2020Farmaceutici Procemsa, a company active in R&D, production, and packaging of food supplements, medical devices, and cosmetics (majority-owned by Investindustrial), merged with OFI to create a combined group. Alessandro and Filippo Sertorio assumed CEO and CFO positions respectively in the new group, enabling synergies across the nutraceutical and cosmeceutical contract manufacturing sector.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Farmaceutici Procemsa: Sister CDMO within the OURVITA group (also majority-owned by Investindustrial) producing food supplements, medical devices and cosmetics for B2B customers. Effectively a combined-platform peer given the 2020 integration, with nearly identical customer base, regulatory certifications and full-service CDMO model as OFI.
• Aenova Group: European CDMO providing contract development and manufacturing services across solid, semi-solid and liquid dosage forms for pharma and consumer health customers. Comparable to OFI in CDMO structure, multi-format manufacturing capabilities, and focus on consumer health and supplement customers.
• Famar: European contract manufacturer offering development and production services for solid, semi-solid, sterile and liquid dosage forms. Operates multiple sites in Europe with similar CDMO structure to OFI, including cosmetic and consumer health contract manufacturing exposure.
• New Penta: Italian nutraceutical and dietary supplement contract manufacturer serving brand customers with formulation, manufacturing and packaging services. Directly comparable on geography (Italy), customer segment (nutraceutical brand owners), and CDMO service model.
• Idifarma: Spanish CDMO specializing in contract development and manufacturing of high-potency, low-volume pharmaceutical and nutraceutical products for indie and mid-sized brand customers. Comparable CDMO service model with similar customer segment focus, though with a smaller, more focused footprint than OFI.

Broad incumbents

• Recipharm: Swedish-headquartered CDMO providing contract development and manufacturing services for pharma and consumer health products across multiple dosage forms. A larger, more pharmaceutical-focused incumbent with overlapping capabilities in softgels, sterile fill-finish and CDMO services relevant to OFI's contract manufacturing model.
• Catalent: Global CDMO leader providing comprehensive development, manufacturing and packaging services across biologics, oral and specialty delivery formats. Comparable to OFI's full-service CDMO positioning but at vastly greater scale and broader format offering, representing the global standard-bearer.
• Lonza: Swiss global CDMO leader serving pharma, biotech and consumer health customers across biologics, small molecules and specialty formats. Comparable CDMO structure and full-service ambition but at multi-billion scale, representing the global incumbent that mid-market players like OFI orbit around.
• Fareva: French-headquartered contract manufacturer providing development, manufacturing and packaging services across pharma, cosmetics and consumer health formats. Comparable to OFI in dermo-cosmetic and consumer health contract manufacturing capabilities and European mid-market positioning.

Regional players

• Stevanato Group: Italian-listed provider of pharmaceutical primary packaging, drug containment solutions and contract manufacturing services with deep GMP and cleanroom capabilities. Overlaps with OFI in Italian-origin, GMP-grade manufacturing and healthcare end-markets, though more weighted toward packaging and glass.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/3606132

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Italian Pharmaceutical Workshop